Quick Answer
CONMED Corp reported Stockholders Equity of $1.03 billion for fiscal year 2025.
CONMED Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.03B | +7.3% |
| 2024 | $962.68M | +15.4% |
| 2023 | $834.22M | +11.9% |
| 2022 | $745.54M | -5.1% |
| 2021 | $785.43M | +10.8% |
| 2020 | $709.04M | -0.2% |
| 2019 | $710.47M | +7.3% |
| 2018 | $662.27M | +4.9% |
| 2017 | $631.43M | +8.8% |
| 2016 | $580.58M | -0.8% |
| 2015 | $585.07M | +0.6% |
| 2014 | $581.30M | -4.1% |
| 2013 | $606.32M | -0.1% |
| 2012 | $607.00M | +5.9% |
| 2011 | $573.07M | -2.3% |
| 2010 | $586.56M | +1.7% |
| 2009 | $576.51M | +6.7% |
| 2008 | $540.22M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.01B | +8.1% | +0.5% |
| June 30, 2025 | $1.00B | +13.7% | +2.6% |
| March 31, 2025 | $977.64M | +14.4% | +1.6% |
| December 31, 2024 | $962.68M | +15.4% | +3.2% |
| September 30, 2024 | $932.90M | +17.2% | +5.8% |
| June 30, 2024 | $881.83M | +13.0% | +3.2% |
| March 31, 2024 | $854.66M | +13.6% | +2.5% |
| December 31, 2023 | $834.22M | +11.9% | +4.8% |
- CONMED Corp showed an increase of +7.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, CONMED Corp’s stockholders equity has grown by 91.2% (from $540.22 million to $1.03 billion).
- The most recent figure is from CONMED Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: